Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

NCT07116694 is registered in ClinicalTrials.gov with BioXcel Therapeutics Inc as lead sponsor.

NCT NCT07116694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
Lead sponsor
BioXcel Therapeutics Inc
Phase
Phase 2
Overall status
Completed
Start date
June 19, 2025
Completion date
October 7, 2025
Enrollment
33 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder, bipolar ii disorder, psychomotor agitation, schizoaffective disorder, schizophrenia, schizophreniform disorders